Sign in
4

Changes in Ownership

Serina Therapeutics, Inc. Filed Acc 0001301120-25-000007

Chief Scientific Officer sold 4,326 shares at $5.20 ($22,495)

  • Chief Scientific Officer acquired 4,326 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Moreadith Randall · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-13 Exercise or conversion : show line 1 in the form 10b5-1 +4,326 $0.06 $260 4,326 D
2025-10-13 Sale : show line 2 in the form 10b5-1 −4,326 $5.20 $22,495 0 D
Open-market sales · 4,326 sh · avg $5.20 · $22,495

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-10-13 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) −4,326 417,186 D
Loading xslF345X05/wk-form4_1760462176.xml…